These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 32305297

  • 1. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
    Muñoz-Montaño W, Cabrera-Galeana P, Alvarado-Miranda A, Villarreal-Garza C, Mohar A, Olvera A, Bargallo-Rocha E, Lara-Medina F, Arrieta O.
    Clin Breast Cancer; 2020 Aug; 20(4):307-316.e1. PubMed ID: 32305297
    [Abstract] [Full Text] [Related]

  • 2. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2-) Breast Cancer.
    Hu Y, Wang S, Ding N, Li N, Huang J, Xiao Z.
    Clin Breast Cancer; 2020 Aug; 20(4):e403-e409. PubMed ID: 32201163
    [Abstract] [Full Text] [Related]

  • 3. Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis.
    Cullinane C, Creavin B, O'Leary DP, O'Sullivan MJ, Kelly L, Redmond HP, Corrigan MA.
    Clin Breast Cancer; 2020 Dec; 20(6):e675-e681. PubMed ID: 32653471
    [Abstract] [Full Text] [Related]

  • 4. Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
    Agostinetto E, Giordano L, Torrisi R, De Sanctis R, Masci G, Losurdo A, Zuradelli M, Tinterri C, Gatzemeier W, Testori A, Alloisio M, De Rose F, Fernandes B, Santoro A.
    Clin Breast Cancer; 2020 Aug; 20(4):e481-e489. PubMed ID: 32279915
    [Abstract] [Full Text] [Related]

  • 5. The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Dan J, Tan J, Huang J, Zhang X, Guo Y, Huang Y, Yang J.
    Breast Cancer; 2020 Sep; 27(5):982-988. PubMed ID: 32306184
    [Abstract] [Full Text] [Related]

  • 6. Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer.
    Caparica R, Richard F, Brandão M, Awada A, Sotiriou C, de Azambuja E.
    Clin Breast Cancer; 2020 Jun; 20(3):262-273.e7. PubMed ID: 32229175
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.
    Koh YW, Lee HJ, Ahn JH, Lee JW, Gong G.
    Tumour Biol; 2014 Oct; 35(10):9823-30. PubMed ID: 24986572
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
    Chen Y, Chen K, Xiao X, Nie Y, Qu S, Gong C, Su F, Song E.
    BMC Cancer; 2016 May 19; 16():320. PubMed ID: 27198767
    [Abstract] [Full Text] [Related]

  • 9. Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2- Breast Cancer: A Prospective Phase II Study.
    Hayashi N, Yagata H, Tsugawa K, Kajiura Y, Yoshida A, Takei J, Yamauchi H, Nakamura S.
    Clin Breast Cancer; 2020 Dec 19; 20(6):462-468. PubMed ID: 33046356
    [Abstract] [Full Text] [Related]

  • 10. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A, Avci N, Kos T, Cubukcu E, Olmez OF, Bulut N, Degirmenci M.
    J BUON; 2015 Dec 19; 20(3):714-22. PubMed ID: 26214622
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L, Zhang H, Liang L, Li G, Fan M, Wu Y, Zhu J, Zhang Z.
    Radiat Oncol; 2014 Dec 18; 9():295. PubMed ID: 25518933
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.